HF 1257 Minnesota House · 2019-2020 Regular Session

Prescription drug benefit transparency and disclosure required.

Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2019
Committee Review
Floor Vote
Governor
Introduced Feb 14, 2019 Last action Mar 26, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
16
Key actions
4
Committee
5
Amendments
1
Mar 26, 2020
Lower · Passed
Committee report, without further recommendation re-refer to Ways and Means
lower
Mar 11, 2020
Lower · Passed
Committee report, without further rec to amend, re-refer to State Government Finance Division
lower
Feb 27, 2020
Introduced
Division action, to adopt as amended and return to Ways and Means
lower
Mar 18, 2019
Committee
Referred by Chair to Health and Human Services Finance Division
lower
Mar 18, 2019
Lower · Passed
Committee report, to adopt and re-refer to Ways and Means
lower
Mar 4, 2019
Lower · Passed
Committee report, to adopt and re-refer to Health and Human Services Policy
lower
Feb 14, 2019
Introduced
Introduction and first reading, referred to Commerce
lower
1 primary · 19 co-sponsors

Sponsors